Privacy Statement
Nexus Australasia Pty Ltd ABN 81 115 828 941 (trading as Zest Healthcare Communications (Zest)) acknowledges and respects the privacy of individuals. The information you provide is protected under the privacy laws of Australia. Zest and Amgen Australia Pty Limited (Amgen) will collect and use your personal information to enrol you in, administer and continue to improve the Otezla® Care program (Program), including providing you with materials and services you request, communicating with you and your healthcare team, including your specialist, GP and pharmacist, in relation to your participation in the Program. Amgen may also use information that it collects as part of the Program in a de-identified form to inform doctors of patient experiences with OTEZLA®, including via promotional materials. By providing the information requested, you consent to Zest and Amgen using this information for these purposes. Generally, you have no obligation to provide any personal information requested by us. However, if you choose to withhold requested personal information, we may not be able to provide you with the services that depend on the collection of that information. Some of the third parties to whom we disclose personal information may be located outside the state or territory in which the information was collected or outside Australia. The state/territories and countries in which such third parties are located will depend on the circumstances. For example, we may disclose personal information to our related companies overseas and to our overseas service providers.
You can find a copy of Zest’s privacy policy at www.zest.com.au. Please address all privacy complaints and requests to update or access information to: Attention: Privacy Officer, Nexus Australasia Pty Ltd, Level 7, 737 Bourke Street, Docklands VIC 3008 OR privacy@symbion.com.au.
For more information on Amgen’s collection, use and disclosure of personal information, refer to our Privacy Statement at www.amgen.com.au and Amgen’s Data Privacy Statement below.
Amgen’s Data Privacy Statement
Amgen may collect and process personal information about you in order to administrate and/or manage the Program. Personal information will include non-sensitive information such as your name and contact information (e.g. phone number and email), as well as sensitive information (e.g. medical history). Amgen will only process your personal information for the purposes mentioned above. Amgen processes your personal data for the duration of the contractual relationship between you and Amgen or for as long as required by applicable laws (e.g. tax laws).
This information may be transferred to a third party for providing services under this Agreement (event organizer, travel agencies) processing and/or processed and securely stored in countries outside of that in which it was collected, such as the United States or other non-EU/EEA countries. Transfers of personal information in countries not deemed adequate are done using appropriate safeguards such as Standard Contractual Clauses. To obtain a copy of these safeguards, please contact your Data Protection Officer at privacyoffice@amgen.com.
Amgen has a legal obligation to report adverse drug events (‘side effects’) to various local and international health authorities (e.g., the U.S. Federal Food and Drug Administration, the European Medicines Agency, the Australian Therapeutic Goods Administration and the New Zealand Medicines and Medical Devices Safety Authority) and to monitor product complaints. Personal information provided to the Program may be (i) monitored by Amgen or its service providers for safety related data and product complaints in order to ensure compliance with these legal reporting requirements, and (ii) reported to local or international health authorities. Amgen may contact you or your physician for additional information to fulfil its reporting obligations. Your personal information may be combined with the information of others who participate in the Program in order to generate aggregated data that does not contain identifying information ("Aggregated Data"). Aggregated Data may be used by Amgen and its service providers to improve and/or refine the Program, to design and implement other patient programs and for research purposes including the identification of trends such as product utilization, adherence or outcomes.
For these purposes, Zest may, on a confidential basis, collect your personal information and disclose it to your healthcare providers, insurers and/or other payers, Amgen and/or Amgen's agents and service providers (e.g., information technology providers). If, from time to time, another service provider is appointed by Amgen to administer the Program, your personal information will be transferred to this service provider to ensure the continuity of the Program services to you.
Amgen is a multi-national company headquartered in the United States. Amgen maintains data centres around the world, including in the European Union and the United States. Amgen may process personal information in global databases that can be accessed by authorized Amgen personnel worldwide. Transfers of personal information among Amgen and its group entities follow applicable laws and our Binding Corporate Rules (BCRs). For more information on the BCRs, including your ability to file a complaint about any processing of your personal information in violation of the BCRs, please visit http://www.amgen.com/bcr/.
Regardless of the country where your personal information is either collected or processed, Amgen maintains appropriate administrative, technical and physical safeguards to protect information about you. You may access, correct or request deletion of your personal information, as well as request your right to data portability, subject to certain restrictions imposed by law, by contacting your Data Protection Officer by email at privacyoffice@amgen.com . You may also lodge a complaint either by contacting your Data Protection Officer or directly to your Data Protection Authority.
